ENTA · Enanta Pharmaceuticals Inc · Documents
$11.94
-0.24 (-1.97%)
At close · Oct 28
Return incl. dividend (before tax)
Q2 2024 earnings call transcript
Market Cap
$354.75M
Shares
29.13M
Volume · Oct 27
319.44K
Avg daily vol (3M)
243.4K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2023-11-20 | — | |
| 10-Q | — | 2023-08-08 | 2023-06-30 | |
| 8-K | — | 2023-08-07 | — | |
| 8-K | — | 2023-06-07 | — | |
| 10-Q | — | 2023-05-09 | 2023-03-31 | |
| 8-K | — | 2023-05-08 | — | |
| 8-K | — | 2023-04-27 | 2023-04-25 | |
| 8-K | — | 2023-03-10 | — | |
| 8-K | — | 2023-03-07 | 2023-03-02 | |
| 10-Q | — | 2023-02-08 | 2022-12-31 | |
| 8-K | — | 2023-02-07 | — | |
| ARS | — | 2023-02-07 | 2022-09-30 | |
| DEFA14A | — | 2023-01-20 | — | |
| DEF 14A | — | 2023-01-20 | 2023-03-02 | |
| 10-K | — | 2022-11-23 | 2022-09-30 | |
| 8-K | — | 2022-11-21 | — | |
| 8-K | — | 2022-08-26 | — | |
| 8-K | — | 2022-08-08 | — | |
| 10-Q | — | 2022-08-08 | 2022-06-30 | |
| 8-K | — | 2022-06-22 | 2022-06-21 | |
| 8-K | — | 2022-05-17 | 2022-05-12 | |
| 8-K | — | 2022-05-09 | — | |
| 10-Q | — | 2022-05-09 | 2022-03-31 | |
| 8-K | — | 2022-03-09 | 2022-03-03 | |
| 8-K | — | 2022-03-08 | 2022-03-03 | |
| 10-Q | — | 2022-02-10 | 2021-12-31 | |
| NT 10-Q | — | 2022-02-10 | 2021-12-31 | |
| 8-K | — | 2022-02-08 | — | |
| DEF 14A | — | 2022-01-21 | 2022-03-03 | |
| DEFA14A | — | 2022-01-21 | — | |
| 10-K | — | 2021-11-24 | 2021-09-30 | |
| 8-K | — | 2021-11-22 | — | |
| 8-K | — | 2021-08-23 | 2021-08-19 | |
| S-3ASR | — | 2021-08-09 | — | |
| 10-Q | — | 2021-08-09 | 2021-06-30 | |
| 8-K | — | 2021-08-05 | — | |
| 8-K | — | 2021-07-16 | 2021-07-14 | |
| 10-Q | — | 2021-05-10 | 2021-03-31 | |
| 8-K | — | 2021-05-06 | — | |
| 8-K | — | 2021-03-05 | 2021-03-02 | |
| 10-Q | — | 2021-02-09 | 2020-12-31 | |
| 8-K | — | 2021-02-08 | — | |
| 8-K | — | 2021-02-05 | — | |
| DEFR14A | — | 2021-01-28 | — | |
| DEFA14A | — | 2021-01-21 | — | |
| DEF 14A | — | 2021-01-21 | 2021-03-02 | |
| 8-K | — | 2020-12-04 | 2020-12-01 | |
| 10-K | — | 2020-11-25 | 2020-09-30 | |
| 8-K | — | 2020-11-23 | — | |
| 10-Q | — | 2020-08-10 | 2020-06-30 |
Showing 51–100 of 109 filings
Key facts
CIK
1177648
CUSIP
29251M106
13F (30d)
15 filings
15 filers
Visit website
Investor relations